文献速递重症综合管理与镇静镇痛心脑血管急症创伤与烧伤

创伤性脑损伤危重患者的血红蛋白值、输血实践与长期结局:CENTER-TBI二次分析

Haemoglobin values, transfusion practices, and long-term outcomes in critically ill patients with traumatic brain injury: a secondary analysis of CENTER-TBI.
PubMed 文献 · Crit Care · 2024-06-14
一句话结论在危重创伤性脑损伤患者中,贫血(Hb<9.5 g/dL)与6个月不良神经结局和死亡率独立相关,Hb每升高1单位不良结局OR 0.78。

本研究为CENTER-TBI的多中心前瞻性观察性研究的二次分析,纳入ICU收治且有入院及第一周血红蛋白数据的创伤性脑损伤患者1590例(1231例有入院Hb)。第一周每日最低Hb按连续变量或<7.5、7.5-9.5、>9.5 g/dL分类,贫血定义为Hb<9.5 g/dL。主要结局为6个月GOSE<5(不良)。多因素logistic回归显示Hb升高与不良神经结局降低独立相关(OR 0.78;95%CI 0.70-0.87);第一周最低Hb<7.5 g/dL(OR 2.09;95%CI 1.15-3.81)和7.5-9.5 g/dL(OR 1.61;95%CI 1.07-2.42)较>9.5 g/dL不良结局风险升高。Hb升高与6个月死亡率降低相关(OR 0.88;95%CI 0.76-1.00),Hb<7.5 g/dL与死亡率升高相关(OR 3.21;95%CI 1.59-6.49)。

要点

  • 危重TBI患者第一周最低Hb<7.5 g/dL较>9.5 g/dL,6个月不良神经结局OR 2.09(95%CI 1.15-3.81),死亡率OR 3.21(95%CI 1.59-6.49)。
  • 第一周最低Hb 7.5-9.5 g/dL较>9.5 g/dL,6个月不良神经结局OR 1.61(95%CI 1.07-2.42)。
  • Hb每升高1单位,6个月不良神经结局OR 0.78(95%CI 0.70-0.87),死亡率OR 0.88(95%CI 0.76-1.00)。
  • 1590例中292例(18.4%)接受至少一次红细胞输注,输注前Hb中位数8.4 g/dL(IQR 7.7-8.5),各中心输血阈值异质性大。
  • 入院时Hb<9.5 g/dL者121例(9.8%),其中Hb<7.5 g/dL者15例(1.2%)。

适用人群与场景

  • 欧洲多中心前瞻性观察性研究CENTER-TBI中收治ICU且有入院时及第一周血红蛋白数据的创伤性脑损伤患者,共纳入1590例,其中1231例有入院Hb值。
  • 平均损伤严重度评分(ISS)33(SD 16),孤立性TBI 502例(40.7%),ICU入院时平均Hb 12.6(SD 2.2)g/dL。

诊断标准与关键阈值

  • 贫血定义为血红蛋白值<9.5 g/dL。
  • 第一周每日最低血红蛋白值分类为<7.5 g/dL、7.5-9.5 g/dL和>9.5 g/dL。
  • 输血实践根据输血前血红蛋白值描述为「限制性」(如<7.5 g/dL)或「宽松性」(如7.5-9.5 g/dL)。
  • 主要结局为6个月格拉斯哥结局扩展量表(GOSE),<5定义为不良结局。

研究设计与关键结果

  • 研究类型:CENTER-TBI的多中心前瞻性观察性研究的二次分析;纳入1590例,1231例有入院Hb值。
  • 第一周最低Hb<7.5 g/dL较>9.5 g/dL,6个月不良神经结局OR 2.09(95%CI 1.15-3.81);7.5-9.5 g/dL较>9.5 g/dL,OR 1.61(95%CI 1.07-2.42)。
  • Hb值升高与6个月不良神经结局降低独立相关(OR 0.78;95%CI 0.70-0.87)。
  • 以6个月死亡率为结局时结果一致:Hb升高与死亡率降低相关(OR 0.88;95%CI 0.76-1.00);Hb<7.5 g/dL与死亡率升高相关(OR 3.21;95%CI 1.59-6.49)。
  • 292例(18.4%)接受至少一次红细胞输注,输注前Hb中位数8.4 g/dL(IQR 7.7-8.5);各中心输血阈值异质性大。
  • 入院时Hb<9.5 g/dL者121例(9.8%),其中Hb<7.5 g/dL者15例(1.2%)。

证据类型、等级与局限

  • 证据类型:多中心前瞻性观察性研究的二次分析。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 作者认为贫血与危重TBI患者长期不良神经结局和死亡率独立相关;本研究为观察性二次分析,未给出输血阈值推荐。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

Haemoglobin (Hb) thresholds and red blood cells (RBC) transfusion strategies in traumatic brain injury (TBI) are controversial. Our objective was to assess the association of Hb values with long-term outcomes in critically ill TBI patients. We conducted a secondary analysis of CENTER-TBI, a large multicentre, prospective, observational study of European TBI patients. All patients admitted to the Intensive Care Unit (ICU) with available haemoglobin data on admission and during the first week were included. During the first seven days, daily lowest haemoglobin values were considered either a continous variable or categorised as < 7.5 g/dL, between 7.5-9.5 and > 9.5 g/dL. Anaemia was defined as haemoglobin value < 9.5 g/dL. Transfusion practices were described as "restrictive" or "liberal" based on haemoglobin values before transfusion (e.g. < 7.5 g/dL or 7.5-9.5 g/dL). Our primary outcome was the Glasgow outcome scale extended (GOSE) at six months, defined as being unfavourable when < 5. Of 1590 included, 1231 had haemoglobin values available on admission. A mean Injury Severity Score (ISS) of 33 (SD 16), isolated TBI in 502 (40.7%) and a mean Hb value at ICU admission of 12.6 (SD 2.2) g/dL was observed. 121 (9.8%) patients had Hb < 9.5 g/dL, of whom 15 (1.2%) had Hb < 7.5 g/dL. 292 (18.4%) received at least one RBC transfusion with a median haemoglobin value before transfusion of 8.4 (IQR 7.7-8.5) g/dL. Considerable heterogeneity regarding threshold transfusion was observed among centres. In the multivariable logistic regression analysis, the increase of haemoglobin value was independently associated with the decrease in the occurrence of unfavourable neurological outcomes (OR 0.78; 95% CI 0.70-0.87). Congruous results were observed in patients with the lowest haemoglobin values within the first 7 days < 7.5 g/dL (OR 2.09; 95% CI 1.15-3.81) and those between 7.5 and 9.5 g/dL (OR 1.61; 95% CI 1.07-2.42) compared to haemoglobin values > 9.5 g/dL. Results were consistent when considering mortality at 6 months as an outcome. The increase of hemoglobin value was associated with the decrease of mortality (OR 0.88; 95% CI 0.76-1.00); haemoglobin values less than 7.5 g/dL was associated with an increase of mortality (OR 3.21; 95% CI 1.59-6.49). Anaemia was independently associated with long-term unfavourable neurological outcomes and mortality in critically ill TBI patients.Trial registration: CENTER-TBI is registered at ClinicalTrials.gov, NCT02210221, last update 2022-11-07.

来源:Crit Care,查看原文。版权归原作者所有。

参考来源

  1. Guglielmi A, Graziano F, Bogossian EG, et al. Haemoglobin values, transfusion practices, and long-term outcomes in critically ill patients with traumatic brain injury: a secondary analysis of CENTER-TBI. Crit Care. 2024. PMID: 38877571. doi:10.1186/s13054-024-04980-6

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。